- Home
- EPRX vs DOUG Comparison
EPRX vs DOUG Comparison
Compare EPRX & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRX
- DOUG
- Stock Information
- Founded
- EPRX 2011
- DOUG 1911
- Country
- EPRX Canada
- DOUG United States
- Employees
- EPRX N/A
- DOUG N/A
- Industry
- EPRX
- DOUG Building operators
- Sector
- EPRX
- DOUG Real Estate
- Exchange
- EPRX NYSE
- DOUG Nasdaq
- Market Cap
- EPRX 137.7M
- DOUG 161.5M
- IPO Year
- EPRX N/A
- DOUG N/A
- Fundamental
- Price
- EPRX $3.94
- DOUG $2.75
- Analyst Decision
- EPRX Strong Buy
- DOUG
- Analyst Count
- EPRX 1
- DOUG 0
- Target Price
- EPRX $9.00
- DOUG N/A
- AVG Volume (30 Days)
- EPRX 17.5K
- DOUG 1.5M
- Earning Date
- EPRX 05-06-2025
- DOUG 05-01-2025
- Dividend Yield
- EPRX N/A
- DOUG N/A
- EPS Growth
- EPRX N/A
- DOUG N/A
- EPS
- EPRX N/A
- DOUG N/A
- Revenue
- EPRX N/A
- DOUG $1,048,791,000.00
- Revenue This Year
- EPRX N/A
- DOUG $17.61
- Revenue Next Year
- EPRX N/A
- DOUG N/A
- P/E Ratio
- EPRX N/A
- DOUG N/A
- Revenue Growth
- EPRX N/A
- DOUG 11.36
- 52 Week Low
- EPRX $2.20
- DOUG $1.00
- 52 Week High
- EPRX $4.48
- DOUG $3.20
- Technical
- Relative Strength Index (RSI)
- EPRX N/A
- DOUG 69.17
- Support Level
- EPRX N/A
- DOUG $2.04
- Resistance Level
- EPRX N/A
- DOUG $3.08
- Average True Range (ATR)
- EPRX 0.00
- DOUG 0.24
- MACD
- EPRX 0.00
- DOUG 0.06
- Stochastic Oscillator
- EPRX 0.00
- DOUG 65.39
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.